http://www.fpnotebook.com/
Trigger Point Injection
- Indication: Myofascial Pain Syndrome
- Symptomatic active Trigger Point and
- Twitch response to pressure with referred pain
- Contraindications
- Known Bleeding Disorder
- Anticoagulation (includes Aspirin in last 3 days)
- Local or systemic infection
- Acute trauma at muscle site
- Anesthetic allergy
- Unsafe injection site
- Example: Intercostal space (risk of Pneumothorax)
- Mechanism
- Mechanical disruption of Trigger Point
- Dry needle "poking" of Trigger Points is also effective
- However, may result in more post-injection soreness
- Technique
- Position patient comfortably
- Patient identifies one to four Trigger Points
- Anticipate initial increased pain on injection
- Local twitch and referred pain confirms placement
- Injecting near Trigger Point may cause irritation
- Start with most tender spot in Trigger Point
- Localize most tender spot within taut muscle-fibers
- Fix tender spot between fingers (1-2 cm in size)
- Prevents from rolling away from needle
- Controls subcutaneous bleeding
- Cleanse overlying skin with Alcohol swab
- Anesthetic selection
- Procaine 0.5%
- Mix 2% Procaine with 3 parts saline
- Lidocaine 1% (Xylocaine 1%)
- Corticosteroid adds no additional benefit
- Needle selection
- Select needle of adequate length
- Prevents burying needle to hub (risk or breakage)
- Select needle of adequate gauge
- Allows for necessary mechanical disruption
- Less likely to be deflected from taut muscle
- Needle examples
- Shallow sites
- Optimal: 22 gauge 1.5 inch needle
- Alternative: Tuberculin syringe (5/8 inch)
- Narrow gauge: 27 gauge 1.5 inch needle
- Deeper sites or obese patient
- Spinal needle (21 gauge 2.5 inch needle)
- Inject Trigger Point
- Select needle as above
- Warn patient of possible pain on injection
- Direct needle at 30 degree angle off skin
- Insert needle into skin 1-2 cm from Trigger Point
- Advance needle into Trigger Point
- Use 0.3 to 0.5 cc anesthetic at each Trigger Point
- Redirect needle and reinject
- Withdraw needle to subcutaneous tissue
- Redirect needle into adjacent tender areas
- Repeat until local twitch or tautness resolves
- Hold direct pressure at injection site for 2 minutes
- Prevents hematoma formation
- Repeat procedure for other Tender Points
- Patient gently stretches injected areas
- Full active range of motion in all directions
- Repeat range of motion three times after injection
- Post-Procedure Instructions (Reduce postinjection flare)
- Patient avoids over-using injected area for 3-4 days
- Maintain active range of motion of injected muscle
- Patient applies ice to injected areas for a few hours
- Anticipate post-injection soreness for 3-4 days
- Complications
- Local Skin Infection at injection site
- Local hematoma at injection site
- Course
- Expect 2-4 months of benefit after injection
- Precautions
- Avoid repeat injection if unsuccessful on 2-3 attempts
- Re-evaluate for possible repeat injection after 4 days
- References
- Ruoff in Pfenninger (1994) Procedures, Mosby, p. 164-7
- Sola in Roberts (1998) Procedures, Saunders, p. 890-901
- Alvarez (2002) Am Fam Physician 65(4):653
- Fomby (1997) Phys Sportsmed 25(2):67
Navigation Tree